Raghupathy Anchala

1.3k total citations · 1 hit paper
26 papers, 893 citations indexed

About

Raghupathy Anchala is a scholar working on Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Raghupathy Anchala has authored 26 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 5 papers in Public Health, Environmental and Occupational Health and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Raghupathy Anchala's work include Blood Pressure and Hypertension Studies (9 papers), Retinal Diseases and Treatments (4 papers) and Retinal Imaging and Analysis (4 papers). Raghupathy Anchala is often cited by papers focused on Blood Pressure and Hypertension Studies (9 papers), Retinal Diseases and Treatments (4 papers) and Retinal Imaging and Analysis (4 papers). Raghupathy Anchala collaborates with scholars based in India, United Kingdom and United States. Raghupathy Anchala's co-authors include Oscar H. Franco, Dorairaj Prabhakaran, Emanuele Di Angelantonio, Rashmi Pant, Nanda Kishore Kannuri, Hassan Khan, Stephen Kaptoge, Patricia Blanco, Amir Shroufi and Rajiv Chowdhury and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and CHEST Journal.

In The Last Decade

Raghupathy Anchala

24 papers receiving 857 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypertension in India

2014 521 citations Raghupathy Anchala, Nanda Kishore Kannuri et al. Journal of Hypertension profile →

Peers

Countries citing papers authored by Raghupathy Anchala

Since Specialization

Citations

This map shows the geographic impact of Raghupathy Anchala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raghupathy Anchala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raghupathy Anchala more than expected).

Fields of papers citing papers by Raghupathy Anchala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raghupathy Anchala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raghupathy Anchala. The network helps show where Raghupathy Anchala may publish in the future.

Co-authorship network of co-authors of Raghupathy Anchala

This figure shows the co-authorship network connecting the top 25 collaborators of Raghupathy Anchala. A scholar is included among the top collaborators of Raghupathy Anchala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raghupathy Anchala. Raghupathy Anchala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	COPD awareness in the urban slums and rural areas around Pune city in India 2021 ·npj Primary Care Respiratory Medicine ·Deesha Ghorpade, Raghupathy Anchala, (unknown), Sapna Madas, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	16
2	Equivalence in Active Pharmaceutical Ingredient of Generic Antihypertensive Medicines Available in Nigeria (EQUIMEDS): A Case for Further Surveillance 2019 ·Global Heart ·Julie Redfern, Harparkash Kaur, Rufus Adesoji Adedoyin, Sandra Ofori, Raghupathy Anchala, Vamadevan S. Ajay, Luciano de Andrade, (unknown), Dina Balabanova, Mahmoud U. Sani	9
3	Improving Hypertension Outcome Measurement in Low- and Middle-Income Countries 2019 ·Hypertension ·Rachel M. Zack, Oluwakemi Okunade, (unknown), (unknown), Celso Amodeo, Raghupathy Anchala, Otávio Berwanger, Norm R.C. Campbell, Yook Chin Chia, Albertino Damasceno, (unknown), Anastase Dzudié, Manuela Fiúza, Fareed Mirza, Dorothea Nitsch, Gbenga Ogedegbe, (unknown), Ernesto L. Schiffrin, António Vaz Carneiro, Peter Lamptey	21
4	MS06.5 Equivalence In Active Pharmaceutical Ingredient of Generic Antihypertensive Medicines Available In Three Nigerian States (EQUIMEDS): A Case For Further Surveillance 2018 ·Global Heart ·Julie Redfern, Rufus Adesoji Adedoyin, Sandra Ofori, Raghupathy Anchala, (unknown), Luciano de Andrade, (unknown), Dina Balabanova, Mahmoud U. Sani	0
5	Perceptions and practices related to diabetes reported by persons with diabetes attending diabetic care clinics: The India 11-city 9-state study 2016 ·Indian Journal of Endocrinology and Metabolism ·G. V. S. Murthy, Raghupathy Anchala, (unknown), (unknown), (unknown), AT Jotheeswaran, (unknown), Vivek Singh, Komal Preet Allagh, (unknown), (unknown), Clare Gilbert	6
6	Is India's policy framework geared for effective action on avoidable blindness from diabetes? 2016 ·Indian Journal of Endocrinology and Metabolism ·G. V. S. Murthy, Shivani Mathur Gaiha, (unknown), Clare Gilbert, Raghupathy Anchala	4
7	Estimating the proportion of persons with diabetes developing diabetic retinopathy in India: A systematic review and meta-analysis 2016 ·Indian Journal of Endocrinology and Metabolism ·(unknown), AT Jotheeswaran, (unknown), (unknown), Raghupathy Anchala, Clare Gilbert	10
8	Eye care infrastructure and human resources for managing diabetic retinopathy in India: The India 11-city 9-state study 2016 ·Indian Journal of Endocrinology and Metabolism ·(unknown), Clare Gilbert, (unknown), (unknown), Raghupathy Anchala, (unknown), (unknown), (unknown), (unknown), Komal Preet Allagh, (unknown), (unknown)	18
9	Physicochemical equivalence of generic antihypertensive medicines (EQUIMEDS): protocol for a quality of medicines assessment 2016 ·BMJ Global Health ·Julie Redfern, Rufus Adesoji Adedoyin, Sandra Ofori, Raghupathy Anchala, Vamadevan S. Ajay, Luciano de Andrade, (unknown), Harparkash Kaur, Dina Balabanova, Mahmoud U. Sani	3
10	Human resources, patient load, and infrastructure at institutions providing diabetic care in India: The India 11-city 9-state study 2016 ·Indian Journal of Endocrinology and Metabolism ·G. V. S. Murthy, Raghupathy Anchala, (unknown), Vivek Singh, (unknown), AT Jotheeswaran, (unknown), (unknown), (unknown), (unknown), (unknown), Clare Gilbert	2
11	Hypertension in India breakdown → 2014 ·Journal of Hypertension ·Raghupathy Anchala, Nanda Kishore Kannuri, Rashmi Pant, Hassan Khan, Oscar H. Franco, Emanuele Di Angelantonio, Dorairaj Prabhakaran	521
12	Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review 2013 ·BMC Public Health ·Amir Shroufi, Rajiv Chowdhury, Raghupathy Anchala, Sarah Stevens, Patricia Blanco, (unknown), Louis Niessen, Oscar H. Franco	45
13	Development and Validation of a Clinical and Computerised Decision Support System for Management of Hypertension (DSS-HTN) at a Primary Health Care (PHC) Setting 2013 ·PLoS ONE ·Raghupathy Anchala, Emanuele Di Angelantonio, Dorairaj Prabhakaran, Oscar H. Franco	15
14	The Role of Decision Support System (DSS) in Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis 2012 ·PLoS ONE ·Raghupathy Anchala, María Paula Panúncio-Pinto, Amir Shroufi, Rajiv Chowdhury, Jean Sanderson, Laura Johnson, Patricia Blanco, Dorairaj Prabhakaran, Oscar H. Franco	30
15	Are Tuberculosis Patients in a Tertiary Care Hospital in Hyderabad, India Being Managed According to National Guidelines? 2012 ·PLoS ONE ·(unknown), (unknown), Srinath Satyanarayana, (unknown), Rony Zachariah, Anthony Harries, Sharath Burugina Nagaraja, Shailaja Tetali, Raghupathy Anchala, Nanda Kishore Kannuri, Krishna R. Murthy, (unknown), (unknown), (unknown)	5
16	‘Decision support system (DSS) for prevention of cardiovascular disease (CVD) among hypertensive (HTN) patients in Andhra Pradesh, India’ – a cluster randomised community intervention trial 2012 ·BMC Public Health ·Raghupathy Anchala, Rashmi Pant, Dorairaj Prabhakaran, Oscar H. Franco	15
17	How Do Patients Who Fail First-Line TB Treatment but Who Are Not Placed on an MDR-TB Regimen Fare in South India? 2011 ·PLoS ONE ·Sharath Burugina Nagaraja, Srinath Satyanarayana, Sarabjit Chadha, (unknown), (unknown), Shanta Achanta, (unknown), (unknown), (unknown), Puneet Dewan, Rony Zachariah, Shailaja Tetali, Raghupathy Anchala, Nanda Kishore Kannuri, Anthony Harries, (unknown)	9
18	The timing of death in patients with tuberculosis who die during anti-tuberculosis treatment in Andhra Pradesh, South India 2011 ·BMC Public Health ·(unknown), Anthony Harries, Rony Zachariah, Srinath Satyanarayana, Shailaja Tetali, Geetanjali Chander, Srinivas Rao, (unknown), (unknown), Raghupathy Anchala, Nanda Kishore Kannuri	25
19	Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: A randomized, double blind, single-dose, crossover study 2007 ·Respiratory Medicine ·(unknown), Bill Brashier, (unknown), Raghupathy Anchala, (unknown), (unknown), Jaideep Gogtay, Sundeep Salvi	20
20	ADDITION OF FORMOTEROL TO TIOTROPIUM PRODUCES BETTER FEV1 AND FVC RESPONSES WHEN MEASURED OVER 24 HOURS FOLLOWING SINGLE-DOSE ADMINISTRATION IN SUBJECTS WITH MODERATE-TO-SEVERE COPD 2005 ·CHEST Journal ·Bill Brashier, (unknown), (unknown), Raghupathy Anchala, (unknown), (unknown), (unknown), Jaideep Gogtay, Sundeep Salvi	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact